S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
Top-Rated StocksTop-Rated
NASDAQ:RGEN

Repligen (RGEN) Insider Trading & Ownership

$161.00
+2.32 (+1.46%)
(As of 09/27/2023 ET)
Compare
Today's Range
$157.46
▼
$161.85
50-Day Range
$157.53
▼
$176.51
52-Week Range
$134.64
▼
$225.62
Volume
303,373 shs
Average Volume
560,838 shs
Market Capitalization
$8.98 billion
P/E Ratio
66.53
Dividend Yield
N/A
Price Target
$199.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Repligen (NASDAQ:RGEN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$158,665.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$5.15 M
Get RGEN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Repligen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RGEN Insider Buying and Selling by Quarter


Repligen Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2023Karen A DawesDirectorSell850$171.38$145,673.00  
5/8/2023Martin D MadausDirectorBuy500$156.18$78,090.00  
5/4/2023Martin D MadausDirectorBuy500$161.15$80,575.00  
11/11/2022Anthony HuntCEOSell25,000$200.00$5,000,000.00  
(Data available from 1/1/2013 forward)












RGEN Insider Trading Activity - Frequently Asked Questions

Who is on Repligen's Insider Roster?

The list of insiders at Repligen includes Anthony Hunt, Christine Gebski, James Bylund, Jon Snodgres, Karen A Dawes, Manner Carrie Eglinton, Martin D Madaus, Nicolas Barthelemy, Ralf Kuriyel, and Thomas F Ryan Jr. Learn more on insiders at RGEN.

What percentage of Repligen stock is owned by insiders?

1.10% of Repligen stock is owned by insiders. Learn more on RGEN's insider holdings.

Which Repligen insiders have been buying company stock?

The following insiders have purchased RGEN shares in the last 24 months: Manner Carrie Eglinton ($109,387.50), and Martin D Madaus ($158,665.00).

How much insider buying is happening at Repligen?

Insiders have purchased a total of 1,625 RGEN shares in the last 24 months for a total of $268,052.50 bought.

Which Repligen insiders have been selling company stock?

The following insiders have sold RGEN shares in the last 24 months: Anthony Hunt ($20,698,453.21), Christine Gebski ($815,784.57), James Bylund ($480,800.00), Jon Snodgres ($2,133,656.28), Karen A Dawes ($3,265,940.40), Nicolas Barthelemy ($474,089.00), Ralf Kuriyel ($1,230,908.80), and Thomas F Ryan Jr ($684,060.00).

How much insider selling is happening at Repligen?

Insiders have sold a total of 135,839 Repligen shares in the last 24 months for a total of $29,783,692.26 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:RGEN) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -